Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

Restrictive lung diseases include conditions that inflame or scar the lungs, including pulmonary fibrosis and sarcoidosis. Obstructive lung diseases include asthma and chronic bronchitis ...

The conditions commonly considered as ILDs include various disorders such as idiopathic pulmonary fibrosis (IPF), connective tissue disease-ILD (CTD-ILD), chronic hypersensitivity pneumonitis, and ...

SOME of the endocrine aspects of sarcoidosis have been discussed in separate reports, but never in a comprehensive review. The purpose of this communication is to emphasize the diversity of ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

Using skin, lung, and blood samples from sarcoidosis ... Gross Professor of Dermatology and the director of Penn's Cutaneous Sarcoidosis & Granulomatous Disease Clinic. "Knowing that type 1 ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.Fourth positive DSMB ...